
Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.
Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.
A care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.
Physician use of EHRs with CDS is associated with increased blood pressure control and lower mean systolic blood pressure across US primary care visits.
Published: June 11th 2021 | Updated:
Published: May 31st 2019 | Updated:
Published: September 7th 2011 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.